DNMT1 and hepatocellular carcinoma: In the present study, the percentage of patients with AFP levels >400 ng/ml was 54.5% in the strongly positive group, which was significantly higher than that in the negative group (16.7%), suggesting that DNMT1 is clinically significant as an additional indicator in routine HCC diagnosis.